Workflow
Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025
Newsfilter· 2025-04-23 20:00
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Monday, April 28, 2025, to review updated safety and efficacy data from the ongoing Phase 2 open-label ADVANCED-2 trial of TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC), including data from patients who have rea ...
Berry Corporation Provides Update on Strong Hedge and Liquidity Position Underpinning Stable Cash Flow Generation; Announces Upcoming Conference Participation
Newsfilter· 2025-04-23 20:00
DALLAS, April 23, 2025 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ:BRY) ("Berry" or the "Company") today provided an update on its hedge and liquidity position, further bolstering the Company's financial strength and visibility in the current commodity price environment. The Company raised the average hedged price in 2026 and 2027 by $6 per barrel on 2.3 MBbls/d. The Company's oil volumes are 73% hedged for the remainder of 2025 and 63% hedged for 2026, based on the midpoint of Berry's full year 202 ...
WiMi Developed a Quantum Computing-Based Feedforward Neural Network (QFNN) Algorithm
Newsfilter· 2025-04-23 20:00
Beijing, April 23, 2025 (GLOBE NEWSWIRE) -- WiMi Developed a Quantum Computing-Based Feedforward Neural Network (QFNN) Algorithm BEIJING, Apr. 23, 2025––WiMi Hologram Cloud Inc. (NASDAQ:WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, announced the development of a Quantum Computing-Based Feedforward Neural Network (QFNN) algorithm aimed at overcoming computational bottlenecks in traditional neural network training. The core innovation of this algorith ...
Sagimet Biosciences Announces Upcoming Presentations at EASL Congress 2025
Newsfilter· 2025-04-23 20:00
SAN MATEO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that three poster presentations featuring additional analyses from the Phase 2b FASCINATE-2 study of denifanstat in MASH will be presented at the European Association for the Study of Liver (EASL) Congress 2025 being held May 7-10, 2025 in Amsterdam, Netherlands ...
DeFi Development Corporation Appoints John Han as Chief Financial Officer
Newsfilter· 2025-04-23 20:00
BOCA RATON, FL, April 23, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corporation (NASDAQ:JNVR) (the "Company") today announced the appointment of Fei "John" Han as Chief Financial Officer, as well as Dan Kang ("DK") as Head of Investor Relations. The new appointments underscore the Company's commitment to building a world-class financial and investor relations function as it scales its crypto-forward treasury strategy. Han brings over 15 years of experience across traditional finance and crypto, with a track ...
Cerence AI and MediaTek Partner to Introduce Multi-Modal Language Models Running on the Edge, Built on NVIDIA
Newsfilter· 2025-04-23 20:00
SHANGHAI and BURLINGTON, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Just ahead of Auto Shanghai 2025, Cerence Inc. (NASDAQ:CRNC) ("Cerence AI"), a global leader pioneering conversational AI-powered user experiences, today announced a new partnership with MediaTek and expanded collaboration with NVIDIA to deliver the next generation of CaLLM™ Edge, its embedded small language model (SLM) purpose-built for automotive user experiences. With new multi-modal capabilities powered by NVIDIA AI Enterprise software, ...
Albion Technology & General VCT PLC: Annual Financial Report
GlobeNewswire· 2025-04-23 19:54
Albion Technology & General VCT PLC LEI Number: 213800TKJUY376H3KN1623 April 2025 Albion Technology & General VCT PLC (the "Company") Annual Report & Financial Statements for the year ended 31 December 2024 Results announcementThe Company's Directors are pleased to attach the Company's Annual Report and Financial Statements for the year ended 31 December 2024. The highlights include: Increase in total shareholder value of 4.73 pence per share (6.57% total gain on opening net asset value per share) (2023: in ...
Fenix Outdoor International AG Later payment of extra dividend
GlobeNewswire· 2025-04-23 19:45
Zug 2025-04-23 Press release: Delayed payment of extra dividend The Board of Directors proposes to the Annual General Meeting that the payment of the extra dividend will take place on Monday 8 December, not as previously planned, on 12 May, but that the ordinary dividend will be paid as planned according to the notice to the Annual General Meeting. See below for details. The reasons for the updated proposal are partly the Group's cyclical liquidity situation, with a strong cash flow in the latter part of th ...
Correction: LHV Group unaudited financial results for Q1 2025
GlobeNewswire· 2025-04-23 19:35
--- At the auditor's suggestion, the corrected version reflects declared but unpaid dividends as a liability. Accordingly, the figures for liabilities, equity, and return on equity have been adjusted. --- The first quarter of the year was characterised by rapid growth in business volumes for LHV, but also by a decrease in profit due to lower interest rates and increased impairments. In Q1 2025, AS LHV Group earned EUR 29.2 million in net profit. AS LHV Pank earned EUR 25.2 million and LHV Bank Ltd EUR 2.1 m ...
BriaCell Announces Four Clinical Data Presentations at ASCO 2025
Newsfilter· 2025-04-23 19:30
PHILADELPHIA and VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW)) (TSX:BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce three clinical data poster presentations and one publish-only abstract at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30 – June 3 at McCormick Place, Chicago, IL. The details ...